These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12432281)

  • 1. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
    Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
    Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
    Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
    Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.
    Fukuhara H; Kuramochi M; Fukami T; Kasahara K; Furuhata M; Nobukuni T; Maruyama T; Isogai K; Sekiya T; Shuin T; Kitamura T; Reeves RH; Murakami Y
    Jpn J Cancer Res; 2002 Jun; 93(6):605-9. PubMed ID: 12079507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of tumor suppressor genes by promoter methylation is important in the pathogenesis of pancreatic cancer.
    Fleming JB; Minna JD
    Cancer Biol Ther; 2002; 1(3):297-9. PubMed ID: 12432282
    [No Abstract]   [Full Text] [Related]  

  • 11. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Fukushima N; Sato N; Ueki T; Rosty C; Walter KM; Wilentz RE; Yeo CJ; Hruban RH; Goggins M
    Am J Pathol; 2002 May; 160(5):1573-81. PubMed ID: 12000709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
    Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
    Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
    Honda T; Tamura G; Waki T; Jin Z; Sato K; Motoyama T; Kawata S; Kimura W; Nishizuka S; Murakami Y
    Jpn J Cancer Res; 2002 Aug; 93(8):857-60. PubMed ID: 12716461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.
    Hong SM; Omura N; Vincent A; Li A; Knight S; Yu J; Hruban RH; Goggins M
    Clin Cancer Res; 2012 Feb; 18(3):700-12. PubMed ID: 22173550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant DNA methylation of the 5' upstream region of Tslc1 gene in hamster pancreatic tumors.
    Shimizu K; Onishi M; Sugata E; Fujii H; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2007 Feb; 353(2):522-6. PubMed ID: 17187758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms.
    Martin ST; Sato N; Dhara S; Chang R; Hustinx SR; Abe T; Maitra A; Goggins M
    Cancer Biol Ther; 2005 Jul; 4(7):728-33. PubMed ID: 15970691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.
    Xu S; Furukawa T; Kanai N; Sunamura M; Horii A
    J Hum Genet; 2005; 50(4):159-167. PubMed ID: 15824892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
    Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M
    Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
    Heller G; Geradts J; Ziegler B; Newsham I; Filipits M; Markis-Ritzinger EM; Kandioler D; Berger W; Stiglbauer W; Depisch D; Pirker R; Zielinski CC; Zöchbauer-Müller S
    Breast Cancer Res Treat; 2007 Jul; 103(3):283-91. PubMed ID: 17260099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.